-
Alternative name
Fda ELISA KIT; Fdafda ELISA KIT; PPUBIRD1_4744 ELISA KIT
-
Catalog
E053500
-
species
Mouse
-
GeneFDA
-
SamplesSerum, Plasma , tissue homogenates,Cell culture supernates,Other biological fluids.
-
Intended UseMouse FDA ELISA Kit allows for the in vitro quantitative determination of FDA , concentrations in serum, Plasma , tissue homogenates and Cell culture supernates and Other biological fluids.
-
StorageFor 5-7days:Store the whole kit at 4℃
For a Long time :Store the Substrate at 4℃, other reagent should store at -20℃.
-
Product Description
specificalIntended Uses: This FDA ELISA kit is intended Laboratory for research use only and is not for use in diagnostic or therapeutic procedures.The Stop Solution changes the color from blue to yellow and the intensity of the color is measured at 450 nm using a spectrophotometer. In order to measure the concentration of FDA in the sample, this FDA ELISA Kit includes a set of calibration standards. The calibration standards are assayed at the same time as the samples and allow the operator to produce a standard curve of Optical Density versus FDA concentration. The concentration of FDA in the samples is then determined by comparing the O.D. of the samples to the standard curve.
Principle of the Assay: This FDA enzyme linked immunosorbent assay applies a technique called a quantitative sandwich immunoassay. The microtiter plate provided in this kit has been pre-coated with a monoclonal antibody specific for FDA. Standards or samples are then added to the microtiter plate wells and FDA if present, will bind to the antibody pre-coated wells. In order to quantitatively determine the amount of FDA present in the sample, a standardized preparation of horseradish peroxidase (HRP)-conjugated polyclonal antibody, specific for FDA are added to each well to "sandwich" the FDA immobilized on the plate. The microtiter plate undergoes incubation, and then the wells are thoroughly washed to remove all unbound components. Next, A and B substrate solution is added to each well. The enzyme (HRP) and substrate are allowed to react over a short incubation period.Only those wells that contain FDA and enzyme-conjugated antibody will exhibit a change in colour. The enzyme-substrate reaction is terminated by the addition of a sulphuric acid solution and the colour change is measured spectrophotometrically at a wavelength of 450 nm.
-